HEALTHCARE (XLV)
143.83
0.00 (0.00%)
Previous Close | 143.83 |
---|---|
Open | - |
Day's Range | N/A - N/A |
52 Week Range | 135.95 - 159.64 |
Volume | 0 |
Market Cap | 379.66M |
Dividend & Yield | 2.308 (1.60%) |
1 Month Average Volume | 8,271,821 |
News & Press Releases
The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding.
Via Talk Markets · March 13, 2025

Via Talk Markets · February 27, 2025

Small caps took another step down this past week as geopolitical events dampened sentiment.
Via Talk Markets · March 10, 2025
The selling has been pretty orderly thus far. The meaning behind this runs deep.
Via Talk Markets · March 10, 2025

I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector.
Via Talk Markets · March 9, 2025

Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as volatility rises quickly?
Via Talk Markets · March 4, 2025

Large cap biopharma and MedTech stocks are leading the healthcare sector higher.
Via Talk Markets · March 4, 2025

The top-performing sector last week was financials, they closed up over 2.8% on the week at their highest weekly and monthly level in history.
Via Talk Markets · March 3, 2025

The stock fell over 7% on Thursday after reports that federal health officials under the Trump administration are re-evaluating Moderna's $590 million contract for bird flu vaccine development.
Via Stocktwits · February 28, 2025

Many analysts are feeling better about the prospects for healthcare stocks in 2025.
Via Talk Markets · February 24, 2025

We’re starting to see money flows into more defensive sectors of the market. This is rather concerning in the near-term.
Via Talk Markets · February 24, 2025